Reishi mushroom has been used as a medicinal mushroom in Chinese traditional medicine for over 2,000 years.Ganoderma lucidum produces a group of triterpenes, and Include polysaccharides,coumarin, mannitol and alkaloids.
The use of reishi has been explored as a complementary adjunct treatment in patients undergoing chemotherapy treatment. A recent trials showed that patients responded more positively when given reishi alongside their chemotherapy regimen. And the studies also showed that patients had improved immune functions which was measured by their elevated levels of immune response cells.
1) Ganoderic acid is increasing disease resistance and normalize bodily functions.
2) Ganoderic acid is enhancing immune system function.
3) Ganoderic acid is anti-tumor,protect liver.
4) Ganoderic acid is activated heart and blood vessel functions,anti-aging, anti-nerve weakness,treat high blood pressure,treat diabetes.
5) Ganoderic acid is prolong life and anti-aging, improve the skin health care
6) Ganoderic acid is anti-radiation, inhibit tumor growth, prevent postoperative
recurrence of cancers, reduce side-effects during chemotherapy or radiotherapy, s
uch as mitigate the pains, suppress hair loss, etc
7) Ganoderic acid is anti-cardiovascular diseases via germanium eliminating
toxins from blood, anti-hypertension, lower blood sugar and cholesterol
8) Ganoderic acid is enhancing detoxification, thus improving liver function
and repairing of liver tissue injury
9) Ganoderic acid is anti-cancer activity
10) Ganoderic acid is immunity system enhancement
1. Ganoderic acid is applied in the field of pharmaceutical, reishi mushroom extract powder can be made into tablets and capsules;
2. Ganoderic acid is applied in the field of health care products, reishi mushroom extract powder can be used as beauty care products for women.
Produce Name: Ganoderic acid
Items | Standards | Results | Method | |
Physical and chemical analysis: | ||||
Description | Brown Fine Powder | Qualified | Visual | |
Assay | 10% | Qualified | HPLC | |
Ash Content | ≤5.0% | 3.56% | CP2015 | |
Loss on Drying | ≤5.0% | 2.72% | CP2015 | |
Mesh Size | 100% pass 80 mesh | Qualified | CP2015 | |
Bulk Density | 40~60g/100ml | 53g/100ml | CP2015 | |
Tap Density | 60~90g/100ml | 71g/100ml | CP2015 | |
Residue analysis: | ||||
Heavy Metal | ≤10ppm | Qualified | CP2015 | |
Pb | ≤2.0ppm | Qualified | GB/T5009.12-2003 | |
As | ≤1.0ppm | Qualified | GB/T5009.11-2003 | |
Hg | ≤0.1ppm | Qualified | GB/T5009.17-2003 | |
Cd | ≤1.0ppm | Qualified | GB/T5009.15-2003 | |
Solvents Residue | ||||
Ethanol | ≤200ppm | Qualified | Eur.Ph 7.0<2.4.24> | |
Pesticides Residue | ||||
Hexachlorobiphenyl | ≤0.2ppm | Qualified | CP2015 | |
Dichlorodiphenyltrichloroethane (DDT) | ≤0.2ppm | Qualified | CP2015 | |
Microbiological: | ||||
Total bacterial count | ≤1000cfg/g | Qualified | GB/T 4789.2 | |
Yeast & Mould | ≤50cfu/g | Qualified | GB/T 4789.15 | |
E.coil | Negative | Negative | GB/T 4789.3 | |
Salmonella | Negative | Negative | GB/T 4789.4 | |
Staphylococcus aureus | Negative | Negative | GB/T 4789.10 | |
Shigella sonnei | Negative | Negative | GB/T 4789.5 | |
General Status: | ||||
B1 Aflatoxin B1 | ≤5.0 μg/kg | Negative | GB 5009.24 | |
B2 Aflatoxin B2 | ≤5.0 μg/kg | Negative | GB 5009.24 | |
G1 Aflatoxin G1 | ≤5.0 μg/kg | Negative | GB 5009.24 | |
G2 Aflatoxin G2 | ≤5.0 μg/kg | Negative | GB 5009.24 | |
GMO Free | Qualified | Qualified |
| |
General Information: | ||||
Conclusion | Conform to specification | |||
Packing | Packed in paper-drums and two plastic-bags inside. N.W:25kgs. I.D.35×H51cm | |||
Storage | Keep in cool & dry place.Keep away from strong light and heat. | |||
Shelf life | 24 months under the conditions above and its original packaging. |